{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:32:33Z","timestamp":1772029953653,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-024-02345-1","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:02:09Z","timestamp":1711638129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating the correlation between prominent viruses and hematological malignancies: a literature review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-2531","authenticated-orcid":false,"given":"Arian","family":"Haghtalab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0528-0830","authenticated-orcid":false,"given":"Milad","family":"Hejazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-4087","authenticated-orcid":false,"given":"Naeem","family":"Goharnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6360-9409","authenticated-orcid":false,"given":"Ali","family":"Yekanlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1072-8270","authenticated-orcid":false,"given":"Kousha","family":"Hazhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9819-1208","authenticated-orcid":false,"given":"Asma","family":"Barghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5983-8769","authenticated-orcid":false,"given":"Zahra","family":"Bazzaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9295-7127","authenticated-orcid":false,"given":"Iman","family":"Allahverdizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0007-4643","authenticated-orcid":false,"given":"Ataollah","family":"GhalibafSabbaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"issue":"4","key":"2345_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1084\/jem.13.4.397","volume":"13","author":"P Rous","year":"1911","unstructured":"Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med. 1911;13(4):397\u2013411.","journal-title":"J Exp Med"},{"key":"2345_CR2","unstructured":"The Nobel Prize in Physiology or Medicine 1966. https:\/\/nobelprizeorg\/prizes\/medicine\/1966\/rous\/facts\/."},{"issue":"3","key":"2345_CR3","first-page":"378","volume":"19","author":"LV Mel\u00e9ndez","year":"1969","unstructured":"Mel\u00e9ndez LV, Hunt RD, Daniel MD, Garc\u00eda FG, Fraser CE. Herpesvirus saimiri. II. Experimentally induced malignant lymphoma in primates. Lab Animal Care. 1969;19(3):378\u201386.","journal-title":"Lab Animal Care"},{"issue":"5","key":"2345_CR4","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/jnci\/50.5.1347","volume":"50","author":"GT Diamandopoulos","year":"1973","unstructured":"Diamandopoulos GT. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the syrian golden hamster by oncogenic DNA simian virus 402. J Natl Cancer Institute. 1973;50(5):1347\u201365.","journal-title":"J Natl Cancer Institute"},{"key":"2345_CR5","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0271","author":"C Shannon-Lowe","year":"2017","unstructured":"Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Phil Trans R Soc London B. 2017. https:\/\/doi.org\/10.1098\/rstb.2016.0271.","journal-title":"Phil Trans R Soc London B"},{"key":"2345_CR6","unstructured":"Bryan ES, Prasanna T. Human T Cell Lymphotropic Virus. Nihgov. 2022."},{"issue":"11","key":"2345_CR7","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJMra1615896","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018;378(11):1029\u201341.","journal-title":"N Engl J Med"},{"key":"2345_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/BLCTT.S361320","volume":"12","author":"A Berhan","year":"2022","unstructured":"Berhan A, Bayleyegn B, Getaneh Z. HIV\/AIDS associated lymphoma: review. Blood Lymphatic Cancer. 2022;12:31\u201345.","journal-title":"Blood Lymphatic Cancer"},{"issue":"24","key":"2345_CR9","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.3390\/cancers14246176","volume":"14","author":"S Silling","year":"2022","unstructured":"Silling S, Kreuter A, Gambichler T, Meyer T, Stockfleth E, Wieland U. Epidemiology of merkel cell polyomavirus infection and merkel cell carcinoma. Cancers. 2022;14(24):6176.","journal-title":"Cancers"},{"issue":"9","key":"2345_CR10","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.3390\/ijms24097803","volume":"24","author":"M Costanzo","year":"2023","unstructured":"Costanzo M, De Giglio MAR, Roviello GN. Deciphering the relationship between SARS-CoV-2 and cancer. Int J Mol Sci. 2023;24(9):7803.","journal-title":"Int J Mol Sci"},{"key":"2345_CR11","unstructured":"About Epstein-Barr Virus (EBV) | CDC. wwwcdcgov. 2022."},{"issue":"7335","key":"2345_CR12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"283","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from burkitt\u2019s lymphoma. The Lancet. 1964;283(7335):702\u20133.","journal-title":"The Lancet"},{"issue":"6","key":"2345_CR13","first-page":"372","volume":"91","author":"J Womack","year":"2015","unstructured":"Womack J, Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician. 2015;91(6):372\u20136.","journal-title":"Am Fam Physician"},{"issue":"1","key":"2345_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1017\/S0950268803008550","volume":"131","author":"I Grotto","year":"2003","unstructured":"Grotto I, Mimouni D, Huerta M, Mimouni M, Cohen D, Robin G, et al. Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults. Epidemiol Infect. 2003;131(1):683\u20139.","journal-title":"Epidemiol Infect"},{"key":"2345_CR15","unstructured":"Mayo C. Mononucleosis - Symptoms and causes. Mayo Clinic. 2018."},{"issue":"5","key":"2345_CR16","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1128\/JCM.44.5.1873-1874.2006","volume":"44","author":"P Tattevin","year":"2006","unstructured":"Tattevin P, Le Tulzo Y, Minjolle S, Person A, Chapplain JM, Arvieux C, et al. Increasing incidence of severe Epstein-Barr virus-related infectious mononucleosis: surveillance study. J Clin Microbiol. 2006;44(5):1873\u20134.","journal-title":"J Clin Microbiol"},{"key":"2345_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12878-016-0059-3","author":"NM Sarwari","year":"2016","unstructured":"Sarwari NM, Khoury JD, Hernandez CMR. Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma. BMC Hematol. 2016. https:\/\/doi.org\/10.1186\/s12878-016-0059-3.","journal-title":"BMC Hematol"},{"issue":"10","key":"2345_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3345\/kjp.2011.54.10.409","volume":"54","author":"KH Son","year":"2011","unstructured":"Son KH, Shin MY. Clinical features of Epstein-Barr virus-associated infectious mononucleosis in hospitalized Korean children. Korean J Pediatr. 2011;54(10):409.","journal-title":"Korean J Pediatr"},{"issue":"12","key":"2345_CR19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3109\/23744235.2015.1082036","volume":"47","author":"SK Topp","year":"2015","unstructured":"Topp SK, Rosenfeldt V, Vestergaard H, Christiansen CB, Von Linstow M-L. Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infection. Infect Dis. 2015;47(12):908\u201314.","journal-title":"Infect Dis"},{"issue":"1\u20132","key":"2345_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2298\/SARH1602056M","volume":"144","author":"R Medovic","year":"2016","unstructured":"Medovic R, Igrutinovic Z, Radojevic-Marjanovic R, Markovic S, Raskovic Z, Simovic A, et al. Clinical and laboratory differences between Epstein-Barr and cytomegalovirus infectious mononucleosis in children. Srp Arh Celok Lek. 2016;144(1\u20132):56\u201362.","journal-title":"Srp Arh Celok Lek"},{"issue":"3","key":"2345_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.24953\/turkjped.2019.03.008","volume":"61","author":"\u0130 \u00c7a\u011flar","year":"2019","unstructured":"\u00c7a\u011flar \u0130, Topal S, \u00c7okboz M, D\u00fczg\u00f6l M, Kara A, Bayram SN, et al. Clinical features and laboratory findings in children hospitalized with acute epstein-barr virus infection: a crosssectional study in a tertiary care hospital. Turk J Pediatr. 2019;61(3):368.","journal-title":"Turk J Pediatr"},{"issue":"197","key":"2345_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D Burkitt","year":"1958","unstructured":"Burkitt D. A sarcoma involving the jaws in african children. Br J Surg. 1958;46(197):218\u201323.","journal-title":"Br J Surg"},{"issue":"9822","key":"2345_CR23","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, et al. Burkitt\u2019s lymphoma. The Lancet. 2012;379(9822):1234\u201344.","journal-title":"The Lancet"},{"issue":"2","key":"2345_CR24","volume":"1","author":"G Massini","year":"2009","unstructured":"Massini G, Siemer D, Hohaus S. EBV in hodgkin lymphoma. Mediterranean J Hematol Infect Dis. 2009;1(2): e2009013.","journal-title":"Mediterranean J Hematol Infect Dis"},{"issue":"1","key":"2345_CR25","first-page":"42","volume":"7","author":"K Goudarzipour","year":"2013","unstructured":"Goudarzipour K, Kajiyazdi M, Mahdaviyani A. Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis. Int J Hematol-Oncol Stem Cell Res. 2013;7(1):42\u20135.","journal-title":"Int J Hematol-Oncol Stem Cell Res"},{"key":"2345_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00071","author":"W Kim","year":"2019","unstructured":"Kim W, Montes-Mojarro IA, Fend F, Quintanilla-Martinez L. Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases. Front Pediatr. 2019. https:\/\/doi.org\/10.3389\/fped.2019.00071.","journal-title":"Front Pediatr"},{"key":"2345_CR27","unstructured":"Thida AM, Gohari P. Extranodal NK-Cell Lymphoma. PubMed. 2022."},{"issue":"10","key":"2345_CR28","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.3390\/cancers12102900","volume":"12","author":"S El Hussein","year":"2020","unstructured":"El Hussein S, Medeiros LJ, Khoury JD. Aggressive NK cell leukemia: current state of the art. Cancers. 2020;12(10):2900.","journal-title":"Cancers"},{"issue":"2","key":"2345_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3324\/haematol.2017.180430","volume":"103","author":"S-B Ng","year":"2017","unstructured":"Ng S-B, Chung T-H, Kato S, Nakamura S, Takahashi E, Ko Y-H, et al. Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes. Haematologica. 2017;103(2):278\u201387.","journal-title":"Haematologica"},{"issue":"11","key":"2345_CR30","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmi.2015.06.026","volume":"21","author":"V Schinzari","year":"2015","unstructured":"Schinzari V, Barnaba V, Piconese S. Chronic hepatitis B virus and hepatitis C virus infections and cancer: synergy between viral and host factors. Clin Microbiol Infect. 2015;21(11):969\u201374.","journal-title":"Clin Microbiol Infect"},{"key":"2345_CR31","unstructured":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383\u2013403."},{"issue":"7","key":"2345_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","volume":"2","author":"JH Kao","year":"2002","unstructured":"Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2(7):395\u2013403.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2345_CR33","first-page":"314","volume":"99","author":"T Wilkins","year":"2019","unstructured":"Wilkins T, Sams R, Carpenter M. Hepatitis B: Screening, prevention, diagnosis, and treatment. Am Fam Physician. 2019;99(5):314\u201323.","journal-title":"Am Fam Physician"},{"issue":"2","key":"2345_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0092-8674(82)90157-X","volume":"29","author":"J Summers","year":"1982","unstructured":"Summers J, Mason WS. Replication of the genome of a hepatitis B\u2013like virus by reverse transcription of an RNA intermediate. Cell. 1982;29(2):403\u201315.","journal-title":"Cell"},{"key":"2345_CR35","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","volume":"479\u2013480","author":"C Seeger","year":"2015","unstructured":"Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479\u2013480:672\u201386.","journal-title":"Virology"},{"issue":"1","key":"2345_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261\u201383.","journal-title":"Hepatology"},{"issue":"2","key":"2345_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.21051","volume":"43","author":"W Yeo","year":"2006","unstructured":"Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology. 2006;43(2):209\u201320.","journal-title":"Hepatology"},{"issue":"4","key":"2345_CR38","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G Raimondo","year":"2008","unstructured":"Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49(4):652\u20137.","journal-title":"J Hepatol"},{"issue":"5 Suppl 1","key":"2345_CR39","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1053\/j.gastro.2004.09.016","volume":"127","author":"C Br\u00e9chot","year":"2004","unstructured":"Br\u00e9chot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology. 2004;127(5 Suppl 1):S56-61.","journal-title":"Gastroenterology"},{"issue":"1","key":"2345_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00281-012-0327-7","volume":"35","author":"G Raimondo","year":"2013","unstructured":"Raimondo G, Caccamo G, Filomia R, Pollicino T. Occult HBV infection. Semin Immunopathol. 2013;35(1):39\u201352.","journal-title":"Semin Immunopathol"},{"issue":"4","key":"2345_CR41","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/10428190902777673","volume":"50","author":"D Rossi","year":"2009","unstructured":"Rossi D, Sala L, Minisini R, Fabris C, Falleti E, Cerri M, et al. Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2009;50(4):604\u201311.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2345_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00277-017-3188-2","volume":"97","author":"C Wang","year":"2018","unstructured":"Wang C, Xia B, Ning Q, Zhao H, Yang H, Zhao Z, et al. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin\u2019s lymphoma in China. Ann Hematol. 2018;97(3):453\u20137.","journal-title":"Ann Hematol"},{"issue":"3","key":"2345_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.dld.2011.09.006","volume":"44","author":"DJ Pinato","year":"2012","unstructured":"Pinato DJ, Rossi D, Minh MT, Toniutto P, Boccato E, Minisini R, et al. Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship. Dig Liver Dis. 2012;44(3):235\u20138.","journal-title":"Dig Liver Dis"},{"key":"2345_CR44","unstructured":"Mehta P, Reddivari AKR. Hepatitis. PubMed. 2022."},{"issue":"Suppl 3","key":"2345_CR45","first-page":"S179","volume":"5","author":"S Kedia","year":"2014","unstructured":"Kedia S, Bhatt VR, Rajan SK, Tandra PK, Behery RAE, Akhtari M. Benign and malignant hematological manifestations of chronic hepatitis C virus infection. Int J Prev Med. 2014;5(Suppl 3):S179.","journal-title":"Int J Prev Med"},{"issue":"10","key":"2345_CR46","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","volume":"42","author":"P Cacoub","year":"1999","unstructured":"Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Charles Piette J, et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum. 1999;42(10):2204\u201312.","journal-title":"Arthritis Rheum"},{"key":"2345_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-016-0076-7","author":"L Tang","year":"2016","unstructured":"Tang L, Marcell L, Kottilil S. Systemic manifestations of hepatitis C infection. Infect Agents Cancer. 2016. https:\/\/doi.org\/10.1186\/s13027-016-0076-7.","journal-title":"Infect Agents Cancer"},{"issue":"4","key":"2345_CR48","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis385","volume":"206","author":"M-H Lee","year":"2012","unstructured":"Lee M-H, Yang H-I, Lu S-N, Jen C-L, You S-L, Wang L-Y, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206(4):469\u201377.","journal-title":"J Infect Dis"},{"issue":"4","key":"2345_CR49","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cld.2005.07.007","volume":"9","author":"MS Sulkowski","year":"2005","unstructured":"Sulkowski MS. Management of the hematologic complications of hepatitis C therapy. Clin Liver Dis. 2005;9(4):601\u201316.","journal-title":"Clin Liver Dis"},{"key":"2345_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55249-w","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang Y, Li J, Zhang W. Hepatitis C virus and risk of extrahepatic malignancies: a case-control study. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-55249-w.","journal-title":"Sci Rep"},{"issue":"2","key":"2345_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00277-010-1055-5","volume":"90","author":"J Kang","year":"2010","unstructured":"Kang J, Cho JH, Suh CW, Lee DH, Oh HB, Sohn YH, et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol. 2010;90(2):159\u201364.","journal-title":"Ann Hematol"},{"issue":"11","key":"2345_CR52","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","volume":"15","author":"L Dal Maso","year":"2006","unstructured":"Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomark Prev. 2006;15(11):2078\u201385.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2345_CR53","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.clml.2014.06.020","volume":"14","author":"A Rios","year":"2014","unstructured":"Rios A. HIV-related hematological malignancies: a concise review. Clin Lymphoma Myeloma Leuk. 2014;14:S96\u2013103.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"2345_CR54","first-page":"395","volume":"3","author":"MP Kieny","year":"1990","unstructured":"Kieny MP. Structure and regulation of the human AIDS virus. JAIDS J Acquired Immune Deficiency Syndromes. 1990;3(4):395\u2013402.","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"2345_CR55","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1054-3589(07)56016-3","volume":"56","author":"PC Angeletti","year":"2008","unstructured":"Angeletti PC, Zhang L, Wood C. The viral etiology of AIDS-associated malignancies. Adv Pharmacol. 2008;56:509\u201357.","journal-title":"Adv Pharmacol"},{"issue":"1","key":"2345_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1067\/mai.2002.125978","volume":"110","author":"EH Moylett","year":"2002","unstructured":"Moylett EH, Shearer WT. HIV: clinical manifestations. J Allergy Clin Immunol. 2002;110(1):3\u201316.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2345_CR57","first-page":"449","volume":"81","author":"TE Coyle","year":"1997","unstructured":"Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clinics. 1997;81(2):449\u201370.","journal-title":"Med Clinics"},{"issue":"2","key":"2345_CR58","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/infdis\/163.2.240","volume":"163","author":"DL Jacobson","year":"1991","unstructured":"Jacobson DL, McCutchan JA, Spechko PL, Abramson I, Smith RS, Bartok A, et al. The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infection. J Infect Dis. 1991;163(2):240\u20136.","journal-title":"J Infect Dis"},{"key":"2345_CR59","doi-asserted-by":"crossref","unstructured":"Little RF, Dunleavy K. Update on the treatment of HIV-associated hematologic malignancies. Hematology 2013, the American Society of Hematology Education Program Book. 2013;2013(1):382\u20138.","DOI":"10.1182\/asheducation-2013.1.382"},{"issue":"9","key":"2345_CR60","doi-asserted-by":"publisher","first-page":"e641","DOI":"10.1016\/S2352-3018(20)30118-1","volume":"7","author":"SM Kimani","year":"2020","unstructured":"Kimani SM, Painschab MS, Horner M-J, Muchengeti M, Fedoriw Y, Shiels MS, et al. Epidemiology of haematological malignancies in people living with HIV. The Lancet HIV. 2020;7(9):e641\u201351.","journal-title":"The Lancet HIV"},{"issue":"7","key":"2345_CR61","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood.2020005469","volume":"139","author":"A Carbone","year":"2022","unstructured":"Carbone A, Vaccher E, Gloghini A. Hematologic cancers in individuals infected by HIV. Blood. 2022;139(7):995\u20131012.","journal-title":"Blood"},{"key":"2345_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.812016","volume":"9","author":"C Rosadas","year":"2022","unstructured":"Rosadas C, Taylor GP. HTLV-1 and Co-infections. Front Med. 2022;9: 812016.","journal-title":"Front Med"},{"issue":"19","key":"2345_CR63","first-page":"2299","volume":"141","author":"CRM Bangham","year":"2023","unstructured":"Bangham CRM. HTLV-1 persistence and the oncogenesis of adult T-cell leukemia\/lymphoma. Blood. 2023;141(19):2299\u2013306.","journal-title":"Blood"},{"key":"2345_CR64","doi-asserted-by":"crossref","unstructured":"Zhang L-l, Wei J-y, Wang L, Huang S-l, Chen J-l. Human T-cell lymphotropic virus type 1 and its oncogenesis. Acta Pharmacologica Sinica. 2017;38(8):1093\u2013103.","DOI":"10.1038\/aps.2017.17"},{"key":"2345_CR65","unstructured":"Human T-lymphotropic virus type 1. wwwwhoint."},{"issue":"3","key":"2345_CR66","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/aid.2006.0140","volume":"23","author":"MF Caskey","year":"2007","unstructured":"Caskey MF, Morgan DJ, Porto AF, Giozza SP, Muniz AL, Orge GO, et al. Clinical manifestations associated with HTLV type I infection: a cross-sectional study. AIDS Res Hum Retroviruses. 2007;23(3):365\u201371.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2345_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1003047","author":"JF Ribeiro","year":"2022","unstructured":"Ribeiro JF, Nobre AFS, Covre LCF, de Almeida VianaMdNdS, Silva IC, dos Santos LM, et al. Hematological changes in human lymphotropic-T virus type 1 carriers. Front Microbiol. 2022. https:\/\/doi.org\/10.3389\/fmicb.2022.1003047.","journal-title":"Front Microbiol"},{"issue":"2","key":"2345_CR68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2222\/jsv.58.125","volume":"58","author":"O Yoshie","year":"2008","unstructured":"Yoshie O. CCR4, HTLV-1 infection, and ATL oncogenesis. Uirusu. 2008;58(2):125\u201340.","journal-title":"Uirusu"},{"issue":"5","key":"2345_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002251","volume":"3","author":"E Majorovits","year":"2008","unstructured":"Majorovits E, Nejmeddine M, Tanaka Y, Taylor GP, Fuller SD, Bangham CR. Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLoS ONE. 2008;3(5): e2251.","journal-title":"PLoS ONE"},{"key":"2345_CR70","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.2741\/1417","volume":"9","author":"M Bindhu","year":"2004","unstructured":"Bindhu M, Nair A, Lairmore MD. Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Front Biosci. 2004;9:2556\u201376.","journal-title":"Front Biosci"},{"issue":"3","key":"2345_CR71","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/v8030074","volume":"8","author":"C Gross","year":"2016","unstructured":"Gross C, Thoma-Kress AK. Molecular mechanisms of HTLV-1 cell-to-cell transmission. Viruses. 2016;8(3):74.","journal-title":"Viruses"},{"issue":"2","key":"2345_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000788","volume":"6","author":"D Mazurov","year":"2010","unstructured":"Mazurov D, Ilinskaya A, Heidecker G, Lloyd P, Derse D. Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog. 2010;6(2): e1000788.","journal-title":"PLoS Pathog"},{"issue":"6","key":"2345_CR73","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/v8060161","volume":"8","author":"CZ Giam","year":"2016","unstructured":"Giam CZ, Semmes OJ. HTLV-1 infection and adult T-cell leukemia\/lymphoma-a tale of two proteins: tax and HBZ. Viruses. 2016;8(6):161.","journal-title":"Viruses"},{"key":"2345_CR74","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fmicb.2012.00330","volume":"3","author":"K Nakano","year":"2012","unstructured":"Nakano K, Watanabe T. HTLV-1 Rex: the courier of viral messages making use of the host vehicle. Front Microbiol. 2012;3:330.","journal-title":"Front Microbiol"},{"key":"2345_CR75","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1743-422X-10-182","volume":"10","author":"AM Fuentes-Gonz\u00e1lez","year":"2013","unstructured":"Fuentes-Gonz\u00e1lez AM, Contreras-Paredes A, Manzo-Merino J, Lizano M. The modulation of apoptosis by oncogenic viruses. Virol J. 2013;10:182.","journal-title":"Virol J"},{"issue":"10","key":"2345_CR76","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26(10):1636\u201343.","journal-title":"Nat Med"},{"issue":"4","key":"2345_CR77","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424\u201332.","journal-title":"J Med Virol"},{"issue":"6","key":"2345_CR78","doi-asserted-by":"publisher","first-page":"2000331","DOI":"10.1002\/bies.202000331","volume":"43","author":"G Saini","year":"2021","unstructured":"Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. BioEssays. 2021;43(6):2000331.","journal-title":"BioEssays"},{"issue":"8","key":"2345_CR79","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41568-018-0015-6","volume":"18","author":"M Greaves","year":"2018","unstructured":"Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018;18(8):471\u201384.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"2345_CR80","first-page":"4089","volume":"20","author":"I Haznedaroglu","year":"2016","unstructured":"Haznedaroglu I, Malkan U. Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies. Eur Rev Med Pharmacol Sci. 2016;20(19):4089\u2013111.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"2345_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000523872","volume":"145","author":"I Gur","year":"2022","unstructured":"Gur I, Giladi A, Isenberg YN, Neuberger A, Stern A. COVID-19 in patients with hematologic malignancies: clinical manifestations, persistence, and immune response. Acta Haematol. 2022;145(3):297\u2013309.","journal-title":"Acta Haematol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02345-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-024-02345-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-024-02345-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T06:12:34Z","timestamp":1717049554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-024-02345-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":81,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1007\/s12032-024-02345-1","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}